Search

Home > OIS Podcast > Alimera CEO Myers Shares Lessons From Iluvien FDA Approval
Podcast: OIS Podcast
Episode:

Alimera CEO Myers Shares Lessons From Iluvien FDA Approval
Category: Business
Duration: 00:17:49
Publish Date: 2014-12-01 23:00:00
Description: The FDA turned away Alimera Sciences’ bid to market Iluvien as a treatment for diabetic macular edema three times before finally giving the green light. President & CEO Dan Myers shares what kept his confidence up during this lengthy review and how Alimera Sciences is positioning Iluvien in the DME market.
Total Play: 0